Smith & Nephew PLC (SNN)
25.01
+0.08
(+0.32%)
USD |
NYSE |
May 08, 16:00
25.01
0.00 (0.00%)
After-Hours: 20:00
Smith & Nephew 1 Year Total Returns (Daily): -19.76% for May 7, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 07, 2024 | -19.76% |
May 06, 2024 | -20.34% |
May 03, 2024 | -20.46% |
May 02, 2024 | -22.33% |
May 01, 2024 | -23.80% |
April 30, 2024 | -23.90% |
April 29, 2024 | -22.39% |
April 26, 2024 | -21.37% |
April 25, 2024 | -21.84% |
April 24, 2024 | -20.54% |
April 23, 2024 | -19.82% |
April 22, 2024 | -21.25% |
April 19, 2024 | -19.81% |
April 18, 2024 | -16.57% |
April 17, 2024 | -16.83% |
April 16, 2024 | -18.16% |
April 15, 2024 | -18.16% |
April 12, 2024 | -17.60% |
April 11, 2024 | -13.55% |
April 10, 2024 | -11.67% |
April 09, 2024 | -10.92% |
April 08, 2024 | -12.04% |
April 05, 2024 | -11.14% |
April 04, 2024 | -10.99% |
April 03, 2024 | -9.62% |
Date | Value |
---|---|
April 02, 2024 | -10.32% |
April 01, 2024 | -9.32% |
March 28, 2024 | -6.14% |
March 27, 2024 | -3.31% |
March 26, 2024 | -3.44% |
March 25, 2024 | -4.33% |
March 22, 2024 | -5.47% |
March 21, 2024 | -6.33% |
March 20, 2024 | -4.58% |
March 19, 2024 | -2.12% |
March 18, 2024 | -3.07% |
March 15, 2024 | -2.65% |
March 14, 2024 | -3.79% |
March 13, 2024 | -1.02% |
March 12, 2024 | 0.46% |
March 11, 2024 | 0.24% |
March 08, 2024 | -0.28% |
March 07, 2024 | -1.47% |
March 06, 2024 | -2.37% |
March 05, 2024 | -6.77% |
March 04, 2024 | -7.19% |
March 01, 2024 | -5.21% |
February 29, 2024 | -4.49% |
February 28, 2024 | -4.78% |
February 27, 2024 | -0.38% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-38.63%
Minimum
Sep 27 2022
43.61%
Maximum
Oct 18 2019
-2.23%
Average
-4.31%
Median
1 Year Total Returns (Daily) Benchmarks
AstraZeneca PLC | 3.64% |
Adaptimmune Therapeutics PLC | -21.43% |
Biodexa Pharmaceuticals Plc | -94.15% |
Verona Pharma PLC | -31.72% |
NuCana PLC | -77.83% |